Acasă › Leucemie mieloasă acută › Iowa › Cedar Rapids
Studii clinice pentru Leucemie mieloasă acută în Cedar Rapids, IA
16 studii pentru Leucemie mieloasă acută caută participanți în și în jurul orașului Cedar Rapids (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · La 25 mi distanță
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
În curs de recrutareFaza 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · La 25 mi distanță
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · La 25 mi distanță
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · La 25 mi distanță
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
În curs de recrutareFaza 3
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · La 25 mi distanță
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
În curs de recrutareFaza 1/2
- University of Iowa Hospital, Iowa City · La 25 mi distanță
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
În curs de recrutareStudiu observațional
- University of Iowa Hospital and Clinics, Iowa City · La 25 mi distanță
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 1
- University of Iowa Health Care, Iowa City · La 25 mi distanță
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
În curs de recrutareFaza 1/2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · La 25 mi distanță
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 3
- University of Iowa Stead Family Children's Hospital, Iowa City · La 25 mi distanță
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
În curs de recrutareFaza 3
- University of Iowa, Iowa City · La 25 mi distanță
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
În curs de recrutareFaza 1
- University of Iowa Hospitals & Clinics, Iowa City · La 25 mi distanță
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
În curs de recrutareFaza 3
- University of Iowa Hospitals and Clinics, Iowa City · La 25 mi distanță
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
În curs de recrutareStudiu observațional
- University of Iowa, Iowa City · La 25 mi distanță
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
În curs de recrutareFaza 1
- University of Iowa Hospitals & Clinics, Iowa City · La 25 mi distanță
Studii pentru Leucemie mieloasă acută în alte orașe
- Houston, TX85 studii
- New York City, NY51 studii
- Boston, MA44 studii
- Baldwin Park, CA40 studii
- Seattle, WA40 studii
- Columbus, OH35 studii
- Philadelphia, PA34 studii
- Durham, NC33 studii
- Atlanta, GA30 studii
- Tampa, FL29 studii
- Chicago, IL26 studii
- Portland, OR25 studii
Alte studii în Cedar Rapids
- Cancer pulmonar cu celule non-pătrate20 studii
- Cancer de sân17 studii
- Cancer (toate tipurile)15 studii
- Mielom multiplu15 studii
- Cancer pulmonar14 studii
- Cancer colorectal13 studii
- Cancer de prostată12 studii
- Carcinom cu celule scuamoase de cap și gât12 studii
- Melanom10 studii
- Accident vascular cerebral10 studii
- Cancer metastatic9 studii
- Cancer endometrial9 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.